Literature DB >> 1249200

Heart muscle performance after experimental viral myocarditis.

C O Adesanya, A H Goldberg, W P Phear, K A Thorp, N A Young, W H Abelmann.   

Abstract

As part of an inquiry into possible antecedents of idiopathic cardiomyopathy, acute experimental coxsackie virus myocarditis was studied for late structural and functional sequelae. Myocarditis was induced in 12- and 22-day-old hamsters by inoculation with coxsackie virus B3. Early viremia occurred, followed by virus replication in heart muscle. Maximum peak developed tension (Tpd) of isometrically contracting isolated heart muscle was depressed 17 and 43% in the animals inoculated at 12 days, and studied 18 and 90 days later, respectively, as compared to their uninoculated controls. In both infected groups, less muscle stretch was required to reach the length at which Tpd was produced. Animals studied 180 days after inoculation did not differ from controls. The muscles from animals inoculated at 22 days of age and studied 18 days later showed a 15% depression of Tpd compared to their controls. Glycerinated muscles from this infected group developed 50% less tension than their controls. The muscles of hamsters inoculated with virus at 22 days and studied 90 and 180 days later showed no change in Tpd. The data suggest that contractility and compliance of heart muscle are decreased 18 days after inoculation, but recover by 90 days if the animals are inoculated at age 22 days. However, if the animals are inoculated at a younger age (12 days), depression of myocardial performance persists for at least an additional 90 days. It is concluded that the inflammatory stage of experimental acute coxsackie virus B3 myocarditis in the Syrian golden hamster may be followed by residual alterations in contractile proteins and myocardial function.

Entities:  

Mesh:

Year:  1976        PMID: 1249200      PMCID: PMC436689          DOI: 10.1172/JCI108312

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Relative susceptibility of young mice and hamsters to Coxsackie B-3 virus.

Authors:  T BURNSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

2.  Some properties of contractile proteins of the heart as studied on the extracted heart muscle preparation.

Authors:  M TAESCHLER; R J BING
Journal:  Circ Res       Date:  1953-03       Impact factor: 17.367

Review 3.  Viral myocarditis and its sequelae.

Authors:  W H Abelmann
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

4.  Polioviruses, coxsackieviruses, and echoviruses comparison of the genomes by RNA hybridization.

Authors:  N A Young
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

5.  Effect of calcium on force-velocity characteristics of glycerinated skeletal muscle.

Authors:  R M Wise; J F Rondinone; F N Briggs
Journal:  Am J Physiol       Date:  1971-10

6.  Progressive Coxsackie viral pancarditis and nephritis.

Authors:  G E Burch; H L Colcolough
Journal:  Ann Intern Med       Date:  1969-11       Impact factor: 25.391

Review 7.  Adult heart disease due to the Coxsackie virus B infection.

Authors:  G S Sainani; E Krompotic; S J Slodki
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

8.  Virus and the heart.

Authors:  W H Abelmann
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

9.  Coxsackie B myopericarditis in adults.

Authors:  W G Smith
Journal:  Am Heart J       Date:  1970-07       Impact factor: 4.749

10.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

View more
  3 in total

1.  Natural history of left ventricular function in neonatal Coxsackie myocarditis.

Authors:  A Rozkovec; G Cambridge; M King; K A Hallidie-Smith
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

Review 2.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

3.  Prognosis and treatment of cardiomyopathy and myocarditis.

Authors:  J B O'Connell; M R Costanzo-Nordin; R S Engelmeier; D E Wallis; J A Robinson; P J Scanlon
Journal:  Heart Vessels Suppl       Date:  1985
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.